Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults

被引：17
|
作者：
Liu, Xiaoqiang [1 ]
Li, Yuhua [2 ]
Wang, Zhongfang [3 ]
Cao, Shouchun [2 ]
Huang, Weijin [2 ]
Yuan, Lin [4 ]
Huang, Yi-Jiao [5 ]
Zheng, Yan [1 ]
Chen, Jingjing [4 ]
Ying, Bo [6 ]
Xiang, Zuoyun [4 ]
Shi, Jin [4 ]
Zhao, Jincun [3 ]
Huang, Zhen [4 ]
Qin, Cheng-Feng [5 ,7 ]
机构：
[1] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China
[2] Natl Inst Food & Drug Control, Beijing, Peoples R China
[3] Guangzhou Inst Resp Hlth, Resp Med, Guangzhou, Guangdong, Peoples R China
[4] Walvax Biotechnol Co Ltd, Kunming, Yunnan, Peoples R China
[5] Beijing Inst Microbiol & Epidemiol, Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China
[6] Suzhou Abogen Biosci Co Ltd, Suzhou, Jiangsu, Peoples R China
[7] Chinese Acad Med Sci, Res Unit Discovery & Tracing Nat Focus Dis, Beijing, Peoples R China
来源：
CELL RESEARCH | 2022年 / 32卷 / 08期
基金：
中国国家自然科学基金; 国家重点研发计划;
关键词：
D O I：
10.1038/s41422-022-00681-3
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：777 / 780
页数：4
相关论文
共 50 条
  • [41] Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities
    Charland, Nathalie
    Gobeil, Philipe
    Pillet, Stephane
    Boulay, Iohann
    Seguin, Annie
    Makarkov, Alexander
    Heizer, Gretchen
    Bhutada, Kapil
    Mahmood, Asif
    Trepanier, Sonia
    Hager, Karen
    Jiang-Wright, Julia
    Atkins, Judith
    Saxena, Pooja
    Cheng, Matthew P.
    Vinh, Donald C.
    Boutet, Philippe
    Roman, Francois
    Van Der Most, Robbert
    Ceregido, Maria Angeles
    Dionne, Marc
    Tellier, Guy
    Gauthier, Jean-Sebastien
    Essink, Brandon
    Libman, Michael
    Haffizulla, Jason
    Frechette, Andre
    D'Aoust, Marc-Andre
    Landry, Nathalie
    Ward, Brian J.
    NPJ VACCINES, 2022, 7 (01)
  • [42] IMMUNOGENICITY AND SAFETY OF HETEROLOGOUS VERSUS HOMOLOGOUS PRIME-BOOST REGIMENS WITH ADENOVIRAL VECTORED AND MRNA SARS-COV-2 VACCINE IN LIVER TRANSPLANT RECIPIENTS
    Sriphoosanaphan, Supachaya
    Suksawatamnuay, Sirinporn
    Srisoonthorn, Nunthiya
    Siripon, Nipaporn
    Thaimai, Panarat
    Makhasen, Wanwisar
    Mungnamtrakul, Nawakodchamon
    Thanapirom, Kessarin
    Nonthasoot, Bunthoon
    Hansasuta, Pokrath
    Komolmit, Piyawat
    GASTROENTEROLOGY, 2022, 162 (07) : S1252 - S1252
  • [43] Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
    Baden, Lindsey R.
    El Sahly, Hana M.
    Essink, Brandon
    Kotloff, Karen
    Frey, Sharon
    Novak, Rick
    Diemert, David
    Spector, Stephen A.
    Rouphael, Nadine
    Creech, C. Buddy
    McGettigan, John
    Khetan, Shishir
    Segall, Nathan
    Solis, Joel
    Brosz, Adam
    Fierro, Carlos
    Schwartz, Howard
    Neuzil, Kathleen
    Corey, Larry
    Gilbert, Peter
    Janes, Holly
    Follmann, Dean
    Marovich, Mary
    Mascola, John
    Polakowski, Laura
    Ledgerwood, Julie
    Graham, Barney S.
    Bennett, Hamilton
    Pajon, Rolando
    Knightly, Conor
    Leav, Brett
    Deng, Weiping
    Zhou, Honghong
    Han, Shu
    Ivarsson, Melanie
    Miller, Jacqueline
    Zaks, Tal
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05): : 403 - 416
  • [44] SARS-CoV-2: Efficacy and Safety of the mRNA-1273 Vaccine
    Metzger, Leandra
    PNEUMOLOGIE, 2022, 76 (03): : 154 - 154
  • [45] Design and Immunogenicity of SARS-CoV-2 DNA Vaccine Encoding RBD-PVXCP Fusion Protein
    Dormeshkin, Dmitri
    Katsin, Mikalai
    Stegantseva, Maria
    Golenchenko, Sergey
    Shapira, Michail
    Dubovik, Simon
    Lutskovich, Dzmitry
    Kavaleuski, Anton
    Meleshko, Alexander
    VACCINES, 2023, 11 (06)
  • [46] Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
    Sun, Yi-Sheng
    Zhou, Jing-Jing
    Zhu, Han-Ping
    Xu, Fang
    Zhao, Wen-Bin
    Lu, Hang-Jing
    Wang, Zhen
    Chen, Shu-Qing
    Yao, Ping-Ping
    Jiang, Jian-Min
    Zhou, Zhan
    VIRUSES-BASEL, 2021, 13 (10):
  • [47] SARS-CoV-2 mRNA Vaccine Immunogenicity in Chronic Inflammatory Arthritis on DMARD Therapy
    Darwish, Nedal
    Jhaveri, Sameer
    Yoganathan, Uma
    Bakillah, Halima
    Chun, Kelly Y.
    Wasser, Thomas
    Freeman, James
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1020 - 1021
  • [48] Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity
    Asamoah-Boaheng, Michael
    Goldfarb, David
    Prusinkiewicz, Martin A.
    Golding, Liam
    Karim, Mohammad E.
    Barakauskas, Vilte
    Wall, Nechelle
    Jassem, Agatha N.
    Marquez, Ana Citlali
    Macdonald, Chris
    O'Brien, Sheila F.
    Lavoie, Pascal
    Grunau, Brian
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [49] SARS-COV-2 MRNA VACCINE IMMUNOGENICITY IN CHRONIC INFLAMMATORY ARTHRITIS ON DMARD THERAPY
    Darwish, N.
    Jhaveri, S.
    Yoganathan, U.
    Bakillah, H.
    Chun, K.
    Wasser, T.
    Freeman, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 952 - 952
  • [50] Squalene in oil-based adjuvant improves the immunogenicity of SARS-CoV-2 RBD and confirms safety in animal models
    Choque-Guevara, Ricardo
    Poma-Acevedo, Astrid
    Montesinos-Millan, Ricardo
    Rios-Matos, Dora
    Gutierrez-Manchay, Kristel
    Montalvan-Avalos, Angela
    Quinones-Garcia, Stefany
    De Grecia Cauti-Mendoza, Maria
    Agurto-Arteaga, Andres
    Ramirez-Ortiz, Ingrid
    Criollo-Orozco, Manuel
    Huaccachi-Gonzales, Edison
    Romero, Yomara K.
    Perez-Martinez, Norma
    Isasi-Rivas, Gisela
    Sernaque-Aguilar, Yacory
    Villanueva-Perez, Doris
    Ygnacio, Freddy
    Vallejos-Sanchez, Katherine
    Fernandez-Sanchez, Manolo
    Guevara-Sarmiento, Luis A.
    Fernandez-Diaz, Manolo
    Zimic, Mirko
    PLOS ONE, 2022, 17 (08):
12345